The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Guidance on dermal absorption
Open accessAbstract
This guidance on the assessment of dermal absorption has been developed to assist notifiers, users of test facilities and Member State authorities on critical aspects related to the setting of dermal absorption values to be used in risk assessments of active substances in Plant Protection Products (PPPs).It is based on the 'scientific opinion on the science behind the revision of the guidance document on dermal absorption' issued in 2011 by the EFSA Panel on Plant Protection Products and their Residues (PPR).The guidance refers to the EFSA PPR opinion in many instances.In addition, the first version of this guidance, issued in 2012 by the EFSA PPR Panel, has been revised in 2017 on the basis of new available data on human in vitro dermal absorption for PPPs and wherever clarifications were needed.Basic details of experimental design, available in the respective test guidelines and accompanying guidance for the conduct of studies, have not been addressed but recommendations specific to performing and interpreting dermal absorption studies with PPPs are given.Issues discussed include a brief description of the skin and its properties affecting dermal absorption.To facilitate use of the guidance, flow charts are included.Guidance is also provided, for example, when there are no data on dermal absorption for the product under evaluation.Elements for a tiered approach are presented including use of default values, data on closely related products, in vitro studies with human skin (regarded to provide the best estimate), data from experimental animals (rats) in vitro and in vivo, and the so called 'triple pack' approach.Various elements of study design and reporting that reduce experimental variation and aid consistent interpretation are presented.A proposal for reporting data for assessment reports is also provided.The issue of nanoparticles in PPPs is not addressed.Data from volunteer studies have not been discussed since their use is not allowed in EU for risk assessment of PPPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fitting Linear Mixed-Effects Models Using lme4
Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835
Mixed-Effects Models in S and S-PLUS
(2001) · Technometrics · doi:10.1198/tech.2001.s574 · Cited by 9,278 · cited 1×
“On the basis of Table B.5, a random-effects multiple regression model (e.g. Pinheiro and Bates, 2002) was fitted, taking the logit of (shrunk) fraction-absorbed as the response variable and estimating fixed effects for the formulation category and concentrate/dilution and random effects for each of…”
Method
Cited by
EFSA Scientific Committee, Hardy, A., Benford, D., Halldorsson, T., Jeger, M. J., Knutsen, H. K., More, S., Naegeli, H., Noteborn, H., Ockleford, C., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5327 · Cited by 416
EFSA Scientific Committee, More, S., Bampidis, V., Benford, D., Bragard, C., Halldorsson, T., Hernández‐Jerez, A., Hougaard Bennekou, S., Koutsoumanis, K., Lambré, C., et al. (2021) · EFSA Journal · doi:10.2903/j.efsa.2021.6768 · Cited by 395
Self-citationSalminen, A. T., Davis, K. J., Felton, R. P., Nischal, N., VonTungeln, L. S., Beland, F. A., Derr, K., Brown, P. C., Ferrer, M., Katz, L. M., et al. (2023) · Toxicology in Vitro · doi:10.1016/j.tiv.2023.105630 · Cited by 25
Metadata
- Authors
- (EFSA), E. F. S. A., Buist, H., Craig, P., Dewhurst, I., Hougaard Bennekou, S., Kneuer, C., Machera, K., Pieper, C., Court Marques, D., Guillot, G., Ruffo, F., & Chiusolo, A.
- Venue
- EFSA Journal
- Publisher
- Wiley
- Published
- 2017-06
- Volume
- 15
- Issue
- 6
- Pages
- e04873-e04873
- ISSN
- 1831-4732 (ISSN-L)
- OpenAlex
- W2729035388
- Cited by
- 215
- References
- 2
- FWCI
- 21.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.